These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 23359498)
41. STS-1 promotes IFN-α induced autophagy by activating the JAK1-STAT1 signaling pathway in B cells. Dong G; You M; Fan H; Ding L; Sun L; Hou Y Eur J Immunol; 2015 Aug; 45(8):2377-88. PubMed ID: 25959715 [TBL] [Abstract][Full Text] [Related]
42. TYK2 Variants in B-Acute Lymphoblastic Leukaemia. Turrubiartes-Martínez E; Bodega-Mayor I; Delgado-Wicke P; Molina-Jiménez F; Casique-Aguirre D; González-Andrade M; Rapado I; Camós M; Díaz-de-Heredia C; Barragán E; Ramírez-Orellana M; Aguado B; Figuera Á; Martínez-López J; Fernández-Ruiz E Genes (Basel); 2020 Nov; 11(12):. PubMed ID: 33260630 [TBL] [Abstract][Full Text] [Related]
43. Enterovirus 71 inhibits cellular type I interferon signaling by downregulating JAK1 protein expression. Liu Y; Zhang Z; Zhao X; Yu R; Zhang X; Wu S; Liu J; Chi X; Song X; Fu L; Yu Y; Hou L; Chen W Viral Immunol; 2014 Aug; 27(6):267-76. PubMed ID: 24905060 [TBL] [Abstract][Full Text] [Related]
44. Therapeutic potential of tyrosine kinase 2 in autoimmunity. Liang Y; Zhu Y; Xia Y; Peng H; Yang XK; Liu YY; Xu WD; Pan HF; Ye DQ Expert Opin Ther Targets; 2014 May; 18(5):571-80. PubMed ID: 24654603 [TBL] [Abstract][Full Text] [Related]
45. Novel Small Molecule Tyrosine Kinase 2 Pseudokinase Ligands Block Cytokine-Induced TYK2-Mediated Signaling Pathways. Zhou Y; Li X; Shen R; Wang X; Zhang F; Liu S; Li D; Liu J; Li P; Yan Y; Dong P; Zhang Z; Wu H; Zhuang L; Chowdhury R; Miller M; Issa M; Mao Y; Chen H; Feng J; Li J; Bai C; He F; Tao W Front Immunol; 2022; 13():884399. PubMed ID: 35693820 [TBL] [Abstract][Full Text] [Related]
46. Banks DA; Ahlbrand SE; Hughitt VK; Shah S; Mayer-Barber KD; Vogel SN; El-Sayed NM; Briken V J Immunol; 2019 Apr; 202(8):2348-2359. PubMed ID: 30833347 [TBL] [Abstract][Full Text] [Related]
47. Coactivation of janus tyrosine kinase (Jak)1 positively modulates prolactin-Jak2 signaling in breast cancer: recruitment of ERK and signal transducer and activator of transcription (Stat)3 and enhancement of Akt and Stat5a/b pathways. Neilson LM; Zhu J; Xie J; Malabarba MG; Sakamoto K; Wagner KU; Kirken RA; Rui H Mol Endocrinol; 2007 Sep; 21(9):2218-32. PubMed ID: 17550976 [TBL] [Abstract][Full Text] [Related]
48. Selective JAK1 inhibitor and selective Tyk2 inhibitor patents. Norman P Expert Opin Ther Pat; 2012 Oct; 22(10):1233-49. PubMed ID: 22971156 [TBL] [Abstract][Full Text] [Related]
50. The Stat3-activating Tyk2 V678F mutant does not up-regulate signaling through the type I interferon receptor but confers ligand hypersensitivity to a homodimeric receptor. Gakovic M; Ragimbeau J; Francois V; Constantinescu SN; Pellegrini S J Biol Chem; 2008 Jul; 283(27):18522-9. PubMed ID: 18456658 [TBL] [Abstract][Full Text] [Related]
51. Defective Jak-Stat activation in renal cell carcinoma is associated with interferon-alpha resistance. Shang D; Liu Y; Ito N; Kamoto T; Ogawa O Cancer Sci; 2007 Aug; 98(8):1259-64. PubMed ID: 17573897 [TBL] [Abstract][Full Text] [Related]
52. Tyk2-dependent bystander activation of conventional and nonconventional Th1 cell subsets contributes to innate host defense against Listeria monocytogenes infection. Hashiguchi T; Oyamada A; Sakuraba K; Shimoda K; Nakayama KI; Iwamoto Y; Yoshikai Y; Yamada H J Immunol; 2014 May; 192(10):4739-47. PubMed ID: 24729620 [TBL] [Abstract][Full Text] [Related]
54. Diamino-1,2,4-triazole derivatives are selective inhibitors of TYK2 and JAK1 over JAK2 and JAK3. Malerich JP; Lam JS; Hart B; Fine RM; Klebansky B; Tanga MJ; D'Andrea A Bioorg Med Chem Lett; 2010 Dec; 20(24):7454-7. PubMed ID: 21106455 [TBL] [Abstract][Full Text] [Related]
55. Respirovirus C protein inhibits activation of type I interferon receptor-associated kinases to block JAK-STAT signaling. Kitagawa Y; Yamaguchi M; Kohno M; Sakai M; Itoh M; Gotoh B FEBS Lett; 2020 Mar; 594(5):864-877. PubMed ID: 31705658 [TBL] [Abstract][Full Text] [Related]
56. Constitutive and induced activation of JAK/Stat pathway in leukemogenic and asymptomatic human T-cell lymphoptropic virus type 1 (HTLV-1) transformed rabbit cell lines. Samaan A; Mahana W Immunol Lett; 2007 Apr; 109(2):113-9. PubMed ID: 17368812 [TBL] [Abstract][Full Text] [Related]
57. Identification of an indispensable role for tyrosine kinase 2 in CTL-mediated tumor surveillance. Simma O; Zebedin E; Neugebauer N; Schellack C; Pilz A; Chang-Rodriguez S; Lingnau K; Weisz E; Putz EM; Pickl WF; Felzmann T; Müller M; Decker T; Sexl V; Stoiber D Cancer Res; 2009 Jan; 69(1):203-11. PubMed ID: 19118004 [TBL] [Abstract][Full Text] [Related]
58. Tyk2 plays a restricted role in IFN alpha signaling, although it is required for IL-12-mediated T cell function. Shimoda K; Kato K; Aoki K; Matsuda T; Miyamoto A; Shibamori M; Yamashita M; Numata A; Takase K; Kobayashi S; Shibata S; Asano Y; Gondo H; Sekiguchi K; Nakayama K; Nakayama T; Okamura T; Okamura S; Niho Y; Nakayama K Immunity; 2000 Oct; 13(4):561-71. PubMed ID: 11070174 [TBL] [Abstract][Full Text] [Related]
59. The growth hormone receptor associates with Jak1, Jak2 and Tyk2 in human liver. Hellgren G; Jansson JO; Carlsson LM; Carlsson B Growth Horm IGF Res; 1999 Jun; 9(3):212-8. PubMed ID: 10502458 [TBL] [Abstract][Full Text] [Related]
60. Simultaneous activation of JAK1 and JAK2 confers IL-3 independent growth on Ba/F3 pro-B cells. Huang HM; Lin YL; Chen CH; Chang TW J Cell Biochem; 2005 Oct; 96(2):361-75. PubMed ID: 15988755 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]